Inventor · disambiguated record
Ali Keshavarz-Shokri
Also filed as: KESHAVARZ-SHOKRI ALI
34 granted patents·16 pending applications·1,058 citations·filing 2004–2024
98Inventor score
Files withVERTEX PHARMA36BIOMED VALLEY DISCOVERIES INC6KESHAVARZ-SHOKRI ALI4SUPERNUS PHARMACEUTICALS INC2VERTEX PHAMRACEUTICALS INC1
Top patents by PatentIndex Score
50 records- 0199US9840499B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2016·Granted Dec 12, 2017·41 cites·1 claims
- 0299US9434717B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2015·Granted Sep 6, 2016·53 cites·5 claims
- 0399US8846718B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2013·Granted Sep 30, 2014·77 cites·23 claims
- 0498US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0598US10787472B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·12 cites·40 claims
- 0698US10081621B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2015·Granted Sep 25, 2018·29 cites·22 claims
- 0798US9150552B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2014·Granted Oct 6, 2015·58 cites·22 claims
- 0898US9051303B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamideVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·59 cites·25 claims
- 0998US8969574B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2014·Granted Mar 3, 2015·61 cites·7 claims
- 1098US8802868B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-CyclopropanecarboxamideVERTEX PHARMA·Filed 2012·Granted Aug 12, 2014·68 cites·40 claims
- 1198US8742122B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2013·Granted Jun 3, 2014·67 cites·7 claims
- 1298US8653103B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2012·Granted Feb 18, 2014·79 cites·1 claims
- 1398US8507687B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2011·Granted Aug 13, 2013·83 cites·5 claims
- 1498US8507534B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2008·Granted Aug 13, 2013·101 cites·23 claims
- 1597US11578062B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2020·Granted Feb 14, 2023·4 cites·19 claims
- 1697US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 1797US10906891B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2018·Granted Feb 2, 2021·13 cites·14 claims
- 1897US10597384B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2017·Granted Mar 24, 2020·17 cites·4 claims
- 1997US9828397B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Nov 28, 2017·23 cites·109 claims
- 2096US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 2196US10253054B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Apr 9, 2019·17 cites·38 claims
- 2296US9464102B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 11, 2016·23 cites·21 claims
- 2396US9314455B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHAMRACEUTICALS INC·Filed 2015·Granted Apr 19, 2016·51 cites·37 claims
- 2496US9163042B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Oct 20, 2015·46 cites·20 claims
- 2594US11773119B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 3, 2023·2 cites·20 claims
- 2693US9676746B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 13, 2017·6 cites·82 claims
- 2792US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 2886US2025084059A1CRYSTALLINE FORMS OF C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 2983US12065432B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2020·Granted Aug 20, 2024·1 cites·18 claims
- 3082US10183927B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 22, 2019·2 cites·26 claims
- 3182US2023331712A1Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3281US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 3380US12187698B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 3473US10738027B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2018·Granted Aug 11, 2020·0 cites·10 claims
- 3572US11390600B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 3671US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3760US2013085158A1Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3858US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3958US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 4057US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4157US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4256US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 4353US2004167203A1Absorption enhancing agentsFiled 2004·Application pending·0 cites
- 4452US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4551US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4650US7300794B2Accelerated culture system for intestinal epithelial cell monolayersSUPERNUS PHARMACEUTICALS INC·Filed 2004·Granted Nov 27, 2007·0 cites·21 claims
- 4750US2009176839A1Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2008·Application pending·0 cites
- 4849US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4946US2007249537A1Absorption enhancing agentsSUPERNUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 5039US2011251253A1Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamideVERTEX PHARMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ali Keshavarz-Shokri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →